Advances in the management of impotence.
With an estimated ten to twenty million men in the United States suffering from impotence, major advances have been made relative to the understanding of the pathophysiology of this disease. These advances have been translated into improved treatment options. Several exciting novel pharmacotherapeutic agents are in the final phase of their clinical trials. These should provide more favorable prospects for men with sexual dysfunction.